Nifty

:

20131.70

Sensex

:

66988.35

35.10 (0.17%)
86.44 (0.13%)

Login

Nifty
Sensex

:
:

20131.70
66988.35

35.10 (0.17%)
86.44 (0.13%)

Jagsonpal Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

Rating :

65/99

BSE: 507789 | NSE: JAGSNPHARM

Watchlist

NSE BSE

395.25

29-Nov-2023

Open
High
Low
Previous Close

391.00
399.05
384.60
385.70

Volume
Traded Value (lacs)
52 Week High
52 Week Low

67564
263.79
514.85
285.00

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

1,032.86
36.45
5

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

921.26
1.27%
6.10

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

5.11
7.25
7.99

EBITDA CAGR (%)

10 Years
5 Years
3 Years

12.33
29.60
12.35

PAT CAGR (%)

10 Years
5 Years
3 Years

28.84
29.92
16.13

P:E (Median)

8 Years
5 Years
3 Years

18.80
18.94
34.48

P:BV (Average)

8 Years
5 Years
3 Years

4.28
4.28
5.18

EV:EBITDA (Average)

8 Years
5 Years
3 Years

277.74
18.14
20.87

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var% Dec 22 Dec 21 Var%
Net Sales 57.83 60.53 -4.46% 60.15 60.60 -0.74% 55.45 51.23 8.24% 60.14 53.91 11.56%
Expenses 49.46 47.62 3.86% 51.52 53.42 -3.56% 50.01 50.44 -0.85% 51.51 48.01 7.29%
EBITDA 8.36 12.90 -35.19% 8.64 7.18 20.33% 5.44 0.78 597.44% 8.63 5.91 46.02%
EBIDTM 14.47% 21.32% 14.36% 11.85% 9.81% 1.53% 14.36% 10.95%
Other Income 2.27 1.12 102.68% 2.00 0.31 545.16% 2.56 0.37 591.89% 1.74 1.95 -10.77%
Interest 0.22 0.03 633.33% 0.15 0.01 1,400.00% 0.20 0.06 233.33% 0.18 0.06 200.00%
Depreciation 0.45 0.20 125.00% 0.39 0.19 105.26% 0.48 0.65 -26.15% 0.33 0.37 -10.81%
PBT 9.96 13.79 -27.77% 10.09 3.83 163.45% 7.32 0.45 1,526.67% 9.87 7.43 32.84%
Tax 2.49 3.38 -26.33% 2.61 0.91 186.81% 1.72 0.12 1,333.33% 2.08 2.14 -2.80%
PAT 7.47 10.41 -28.24% 7.48 2.92 156.16% 5.60 0.33 1,596.97% 7.78 5.29 47.07%
PATM 12.92% 17.20% 12.43% 4.82% 10.10% 0.63% 12.94% 9.81%
EPS 2.85 3.97 -28.21% 2.85 1.11 156.76% 2.14 0.12 1,683.33% 2.97 2.02 47.03%

Description Jun 23 Jun 22 Var% Mar 23 Mar 22 Var% Dec 22 Dec 21 Var% Sep 22 Sep 21 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 233.57 236.71 217.58 187.95 158.57 166.83 126.53 143.87 143.49 138.15 143.85 Net Sales Growth 3.23% 8.79% 15.76% 18.53% -4.95% 31.85% -12.05% 0.26% 3.87% -3.96% Cost Of Goods Sold 88.54 93.10 88.96 80.78 56.19 72.85 61.11 58.95 59.13 68.68 64.71 Gross Profit 145.03 143.61 128.62 107.17 102.38 93.98 65.42 84.92 84.36 69.47 79.14 GP Margin 62.09% 60.67% 59.11% 57.02% 64.56% 56.33% 51.70% 59.03% 58.79% 50.29% 55.02% Total Expenditure 202.50 202.56 192.56 168.87 150.04 157.49 137.64 138.10 131.68 129.42 133.17 Power & Fuel Cost - 0.29 0.47 0.52 0.76 1.41 1.00 2.12 2.26 1.77 2.23 % Of Sales - 0.12% 0.22% 0.28% 0.48% 0.85% 0.79% 1.47% 1.58% 1.28% 1.55% Employee Cost - 65.18 57.67 53.98 50.37 46.61 41.88 40.95 37.84 32.11 37.83 % Of Sales - 27.54% 26.51% 28.72% 31.77% 27.94% 33.10% 28.46% 26.37% 23.24% 26.30% Manufacturing Exp. - 0.52 1.05 0.62 0.51 0.73 0.96 1.34 1.70 1.01 1.57 % Of Sales - 0.22% 0.48% 0.33% 0.32% 0.44% 0.76% 0.93% 1.18% 0.73% 1.09% General & Admin Exp. - 22.29 28.47 18.75 23.55 19.03 16.31 16.44 13.61 9.64 8.55 % Of Sales - 9.42% 13.08% 9.98% 14.85% 11.41% 12.89% 11.43% 9.48% 6.98% 5.94% Selling & Distn. Exp. - 18.61 13.88 12.99 17.45 13.20 11.25 13.74 12.96 11.53 14.36 % Of Sales - 7.86% 6.38% 6.91% 11.00% 7.91% 8.89% 9.55% 9.03% 8.35% 9.98% Miscellaneous Exp. - 2.57 2.05 1.22 1.20 3.66 5.14 4.56 4.19 4.67 14.36 % Of Sales - 1.09% 0.94% 0.65% 0.76% 2.19% 4.06% 3.17% 2.92% 3.38% 2.73% EBITDA 31.07 34.15 25.02 19.08 8.53 9.34 -11.11 5.77 11.81 8.73 10.68 EBITDA Margin 13.30% 14.43% 11.50% 10.15% 5.38% 5.60% -8.78% 4.01% 8.23% 6.32% 7.42% Other Income 8.57 5.73 3.43 4.39 2.53 1.43 0.46 0.47 0.66 0.11 0.06 Interest 0.75 0.41 0.28 0.51 0.51 0.75 0.66 2.64 5.30 4.46 5.38 Depreciation 1.65 1.21 1.53 1.09 1.13 1.02 0.32 1.99 3.09 2.71 2.83 PBT 37.24 38.27 26.64 21.87 9.41 9.00 -11.63 1.60 4.08 1.67 2.53 Tax 8.90 8.09 7.79 4.81 1.54 1.79 -0.08 2.53 0.82 0.50 0.41 Tax Rate 23.90% 23.24% 29.24% 21.99% 16.37% 19.89% 0.69% 17.57% 20.10% 29.94% 16.21% PAT 28.33 26.72 18.86 17.06 7.87 7.22 -11.55 11.86 3.25 1.17 2.12 PAT before Minority Interest 28.33 26.72 18.86 17.06 7.87 7.22 -11.55 11.86 3.25 1.17 2.12 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 12.13% 11.29% 8.67% 9.08% 4.96% 4.33% -9.13% 8.24% 2.26% 0.85% 1.47% PAT Growth 49.50% 41.68% 10.55% 116.77% 9.00% - - 264.92% 177.78% -44.81% EPS 10.81 10.20 7.20 6.51 3.00 2.76 -4.41 4.53 1.24 0.45 0.81

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 158.89 132.76 121.93 111.03 104.47 98.05 109.91 98.36 95.43 98.59 Share Capital 13.10 13.10 13.10 13.10 13.10 13.10 13.10 13.10 13.10 13.10 Total Reserves 137.03 119.66 108.83 97.93 91.37 84.95 96.81 85.27 82.33 85.49 Non-Current Liabilities 8.48 4.49 1.88 3.09 3.12 3.19 3.26 3.61 3.60 4.08 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 1.07 1.26 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 35.18 34.14 40.40 34.57 28.19 28.58 29.44 57.31 55.19 53.58 Trade Payables 16.36 18.55 18.05 11.71 11.86 9.09 8.98 9.73 7.87 5.08 Other Current Liabilities 10.81 7.70 10.89 8.16 5.60 6.10 7.12 6.61 6.24 5.48 Short Term Borrowings 0.00 0.00 6.79 6.40 3.79 8.30 7.93 38.49 39.31 35.96 Short Term Provisions 8.01 7.89 4.67 8.30 6.95 5.09 5.41 2.48 1.77 7.06 Total Liabilities 202.55 171.39 164.21 148.69 135.78 129.82 142.61 159.28 154.22 156.25 Net Block 24.28 22.60 25.72 24.44 21.64 21.32 21.59 51.61 51.96 56.41 Gross Block 33.25 58.13 60.12 58.17 55.00 53.66 52.88 90.35 87.61 87.01 Accumulated Depreciation 11.75 35.53 34.40 33.74 33.36 32.34 31.28 38.74 35.65 30.60 Non Current Assets 30.39 55.14 43.73 52.39 38.23 35.20 32.50 58.32 58.43 64.94 Capital Work in Progress 0.00 0.00 0.00 1.90 3.95 3.04 0.00 0.00 0.00 2.35 Non Current Investment 1.12 28.86 12.06 11.39 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 0.69 1.07 5.66 14.53 12.63 10.84 10.90 6.71 6.47 6.19 Other Non Current Assets 4.29 2.62 0.29 0.13 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 172.17 116.25 120.48 96.31 97.56 94.61 110.11 100.96 95.79 91.31 Current Investments 0.00 21.81 3.25 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 20.68 29.74 29.72 29.32 32.69 51.43 47.62 39.84 33.06 30.59 Sundry Debtors 20.87 15.58 12.66 21.45 20.75 25.15 39.41 41.69 44.89 45.22 Cash & Bank 114.63 25.25 60.23 40.49 38.53 14.51 20.06 15.53 15.02 12.60 Other Current Assets 16.00 1.41 0.27 0.52 5.58 3.51 3.03 3.90 2.83 2.90 Short Term Loans & Adv. 14.85 22.47 14.34 4.52 4.64 3.27 2.80 3.90 2.83 2.90 Net Current Assets 136.99 82.11 80.08 61.74 69.37 66.03 80.68 43.65 40.60 37.73 Total Assets 202.56 171.39 164.21 148.70 135.79 129.81 142.61 159.28 154.22 156.25

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity 46.66 6.91 28.22 11.89 30.90 -1.58 -3.24 9.04 4.30 7.52 PBT 34.81 26.64 21.87 9.41 9.00 -11.63 14.40 4.08 1.67 2.53 Adjustment 9.25 -1.40 -2.09 -0.57 0.33 1.26 -8.63 7.73 7.05 8.15 Changes in Working Capital 9.88 -11.46 11.59 4.84 19.71 8.79 -6.13 -1.96 -4.09 -2.65 Cash after chg. in Working capital 53.93 13.79 31.37 13.69 29.05 -1.58 -0.36 9.85 4.63 8.02 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -7.28 -6.87 -3.15 -1.80 1.85 0.00 -2.88 -0.82 -0.33 -0.51 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -57.67 -25.78 -2.26 -11.07 -0.83 -3.37 41.29 -2.09 -0.46 -1.21 Net Fixed Assets 24.88 1.99 -0.05 -1.12 -2.25 -3.82 37.47 -2.74 1.75 -1.28 Net Investments 49.55 -35.36 -3.92 -11.39 0.00 0.00 0.00 0.00 0.00 0.00 Others -132.10 7.59 1.71 1.44 1.42 0.45 3.82 0.65 -2.21 0.07 Cash from Financing Activity -0.46 -17.55 -6.83 -1.82 -6.05 -0.60 -33.52 -6.43 -1.42 -4.04 Net Cash Inflow / Outflow -11.47 -36.42 19.13 -1.01 24.02 -5.55 4.53 0.52 2.41 2.26 Opening Cash & Equivalents 22.53 58.94 39.81 40.82 14.51 20.06 15.53 15.02 12.60 10.34 Closing Cash & Equivalent 11.05 22.53 58.94 39.81 38.53 14.51 20.06 15.53 15.02 12.60

Financial Ratios

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 57.30 50.68 43.55 39.39 36.89 34.43 38.96 34.55 33.43 32.86 ROA 14.29% 11.24% 10.90% 5.53% 5.43% -8.48% 7.86% 2.08% 0.75% 1.37% ROE 18.89% 15.28% 15.70% 7.88% 7.72% -12.01% 12.32% 3.65% 1.35% 2.47% ROCE 24.15% 21.23% 19.43% 9.46% 9.80% -10.52% 14.26% 7.32% 4.93% 6.57% Fixed Asset Turnover 5.63 4.10 3.18 2.80 3.07 2.38 2.03 1.62 1.59 1.68 Receivable days 25.87 21.26 33.13 48.57 50.22 93.07 102.03 109.58 118.23 109.72 Inventory Days 35.78 44.76 57.34 71.38 92.03 142.78 110.02 92.27 83.52 76.13 Payable days 68.44 75.08 67.24 34.46 31.91 27.07 22.17 21.36 15.26 9.95 Cash Conversion Cycle -6.79 -9.07 23.23 85.49 110.33 208.78 189.88 180.49 186.49 175.90 Total Debt/Equity 0.00 0.00 0.06 0.06 0.04 0.09 0.08 0.43 0.45 0.42 Interest Cover 85.28 94.48 43.59 19.31 13.08 -16.69 6.44 1.77 1.37 1.47

Top Investors:

vanaja sundar iyer

mukul mahavir agrawal

investor education and protection fund (iepf)

sanjiv kumar dudeja

lincoln p coelho

Annual Reports:

News Update:

Jagsonpal Pharma - Quarterly Results
3rd Nov 2023, 13:58 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback